NDPSC record of reasons, 52nd meeting, 19-20 February 2008
National Drugs and Poisons Schedule Committee
The Record of the Reasons contains the basis of scheduling decisions and other outcomes arising from the meeting. Please note that the Record of the Reasons includes extracts from the NDPSC minutes which have been edited to remove confidential information.
*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
NDPSC Record of reasons, Meeting 52 (pdf,543kb)
Contents
Glossary
1. Premiminary matters
- 1.1 Opening of the meeting
- 1.2 Adoption of the agenda
- 1.3 Action sheet
- 1.4 Minutes of previous meeting
- 1.5 Administration
- 1.6 Item deleted
- 1.7 Procedural matters
- 1.8 NDPSC working parties
- 1.8.1 Fluorides Working Party
- 1.8.2 Item deleted
- 1.9 Proposed routine changes to the SUSDP
2. Proposed changes/additions to Parts 1 to 3 and Part 5 of the Standard for the Uniform Scheduling of Drugs and Poisons
- 2.1 SUSDP, Part 1
- 2.1.1 Interpretation of aerosol concentration in the SUSDP
- 2.2 SUSDP, Part 2
- 2.3 SUSDP, Part 3
- 2.4 SUSDP, Part 5
- 2.4.1 The Uniform Paint Standard (Appendix I)
Agricultural/veterinary, industrial and domestic chemicals
3. Matters arising from the minutes of the previous meeting
- 3.1 Formaldehyde and paraformaldehyde
4. Other outstanding matters from previous meetings
- 4.1 2,4-dichlorophenoxyacetic acid (2,4-D)
- 4.2 Metribuzin
- 4.3 Lead in inks
- 4.4 Methylnorbornylpyridine (MNBP)
5. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
-
- 5.1.1 Pyrithione zinc
- 5.1.2 Eyelash/brow tints containing phenylenediamine or toluenediamine
- 5.2 SUSDP, Part 5
- 5.2.1 1,4-butanediol
6. Matters referred by the Australian Pesticides and Veterinary Medicines Authority
- 6.1 Chlorantraniliprole
- 6.2 Dirlotapide
- 6.3 Esfenvalerate
- 6.4 Methiocarb
- 6.5 Spinetoram
- 6.6 Pyroxsulam
7. Matters referred by the Office of Chemical Safety (OCS) or the National Industrial Chemicals Notification and Assessment Scheme (NICNAS)
8. Other matters for consideration
- 8.1 Veterinary vaccines
9. Information items (Ag/vet, industrial & domestic chemical)
Pharmaceuticals
10. Matters arising from the minutes of the previous meeting
11. Other outstanding matters from previous meetings
- 11.1 Non-phenothiazine sedating antihistamines for use in children
- 11.2 Piper methysticum (kava)
- 11.3 Dienestrol
- 11.4 Ribavirin
- 11.5 Codeine and Ibuprofen
12. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
- 12.1 SUSDP, Part 4
- 12.1.1 Paracetamol
- 12.1.2 Zolpidem
- 12.2 SUSDP, Part 5
13. Matters referred by the registration process for prescription medicines
- 13.1 New substances (not seen before by NDPSC)
- 13.1.1 Methoxy polyethylene glycol-epoetin beta
- 13.1.2 Panitumumab
- 13.2 For information (substances already scheduled)
- 13.2.1 Human coagulation factor VIII and human von willebrand factor
- 13.2.2 Prothrombin complex concentrate
- 13.2.3 Paliperidone
- 13.2.4 Abatacept
14. Other matters for consideration
15. Matters referred by the Medicines Evaluation Committee (MEC)
16. Matters referred by the Medicines Classification Committee (MCC) of New Zealand
- 16.1 Boron/boric acid
17. Minutes of the Adverse Drug Reactions Advisory Committee (ADRAC)
18. Minutes of the Medical Device Evaluation Committee (MDEC)
19. Information items (pharmaceuticals)
20. Gazettal notices
21. Amendments to the SUSDP
- 21.1 Editorial changes and errata
- 21.1.1 Editorial - Sedating antihistamines (Brompheniramine, Chlorpheniramine, Dexchlorpheniramine, Diphenhydramine, Doxylamine, Pheniramine, Promethazine, Trimeprazine &Triprolidine)
- 21.1.2 Editorials - Child-resistant packaging
- 21.1.3 Errata - Paracetamol
- 21.1.4 Errata - Ciclopirox
- 21.1.5 Editorial - Colecalciferol (Cholecalciferol)
- 21.2 SUSDP 22 amendment 3 - Editorials (Cadmium compounds, blood products)